Published online by Cambridge University Press: 13 June 2014
General aspects of research funding in the biomedical sciences are briefly discussed and some specific issues of policy considered, as they relate particularly to the Health Research Board's Unit strategy. The origins, objectives and workings of the Board's Schizophrenia Research Unit are elaborated, in relation to contemporary perspectives of this illness as a neuro-developmental disorder, and the extent of progress made over it's first year of operation is outlined. It is argued that the ‘neurodevelopmental hypothesis’ now has substantial foundations; it provides an important conceptual focus, both for the field in general and for the Health Research Board's Schizophrenia Research Unit in particular.